Related resources and publications
CD28-targeting therapies
FcγR mouse models for efficacy and PK/PD
Multispecific CD73/PD-1 targeting
Safety and activity of a conditionally active cLAG3-IL2
CD28xVISTA bispecific antibodies in immunotherapy
Drug delivery to the brain (TFRC)
BRGSF-HIS & hFcγR to assess cell depletion
Novel PD-1 targeted IL-2Rβ/γ agonist
CD3 binding T-cell engagement
Humanized Mouse Model of Fcγ Receptors
CTLA-4 & survival in a colorectal cancer model
PD-1 & strong tumor growth inhibition
hPD-1 to evaluate novel cancer therapies
CD3 and BRGSF-HIS to assess IrAEs
Anti hCD39 to promote anti-tumor immunity
BRGSF-HIS & hVISTA for immunotherapies
BRGSF-HIS & CD3ε in CRS
hSTING & anti-tumor response in cold tumors
VISTA in the tumor microenvironment
anti-hVISTA against poorly immunogenic tumors
Theranostics
Eur J Nucl Med Mol Imaging
JCI Insight
JCI Insight
Mol Cancer Ther
Nat Commun
Hum Mol Genet
Front Immunol
Hear Res
Front Immunol
Cell Mol Life Sci
Front Immunol
J Allergy Clin Immunol
Proc Natl Acad Sci U S A
Immunohorizons
PLoS One
J Thromb Haemost
Pancreatology
Acta Biomater
Matrix Biol
Front Immunol
J Invest Dermatol
J Allergy Clin Immunol
Int J Pharmac
J Immunother Cancer
Prog Neurobiol
Nat Cancer
Cell Rep
Sci Rep
Mol Cancer
Neurobiol Dis
ACS Pharmacol Transl Sci
Mol Cancer Ther
Nat Med
Cell Death Dis
Matrix Biol
Bioconjug Chem
Proc Natl Acad Sci U S A
Cancer Discov
J Bone Miner Res
Nat Chem Biol
Cell
Nat Chem Biol
J Immunother Cancer
Sci Adv
Hum Genet
Eur J Microbiol Immunol
J Alzheimers Dis
Cell Physiol Biochem
Invest Ophthalmol Vis Sci
JCI Insight
PLoS One
EMBO J
Circ Res
Brain
PLoS One
J Biol Chem
J Am Heart Assoc
J Control Release
Arterioscler Thromb Vasc Biol
Physiol Rep
Blood
J Bone Miner Res
J Neurosci
Cell Death Differ
Cell Mol Life Sci
Diabetes
Humanized ICP in immuno-oncology
Immuno-oncolology models
Immuno-oncolology models
Humanized mouse models
T-cell engager
Assess toxicity with ICP
T-cell engager
Humanized PD-1 & GITR mouse
T-cell engager CD3
Assess T-cell engager in BRGSF-HIS
Humanized PD-1/PD-L1 mouse and cell line
Humanized HSA/hFcRn mouse
Humanized ICP mouse and cell lines
Assess T-cell engager in BRGSF-HIS
Humanized VISTA mouse & Pharmacokinetics
Humanized cLC model - Bispecific antibody development
Targeting the human CD47/SIRPα axis
BRGSF-HIS as model for acute implant-associated osteomyelitis
VISTA - safety and PK profiling
Therapeutic efficacy and pharmacokinetics
Physiological relevancy in preclinical models